Here's Why Teva Stock (NYSE:TEVA) Fell and Then Rose Yesterday - TipRanks.com
Teva walks away from PhRMA after similar move by AbbVie
Teva Pharmaceuticals: Key Facts And Trends Of 2015-2016 (NYSE:TEVA) | Seeking Alpha
Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
Teva Pharmaceuticals will pay $420 million in a federal case
Teva to pay $225M to settle cholesterol drug price-fixing charges - ABC News
Intas' Binesh Chudgar On Buying Teva's Europe Assets - YouTube
Allergan CEO on deal with Teva
Teva to pay $225 million fine and divest cholesterol drug to settle price-fixing charges | CNN Business
Teva Pharmaceutical to Cut 14,000 Jobs - WSJ
TEVA Pharmaceutical Industries Limited Visits the NYSE - YouTube
FDA approves Teva's generic EpiPen after yearslong delay
Teva to pay NIS 75 million to Israel authorities to settle foreign bribe claims - The Times of Israel
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Pharma Plunges After Two U.S. Copaxone Patents Invalidated | Investor's Business Daily
Teva Pharmaceuticals: Key Facts And Trends Of 2015-2016 (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals Q4 2016 Earnings
Opioid maker Teva agrees to tentative $4.25 billion deal - The Washington Post
Teva Pharmaceuticals - Wikipedia
News of Charges in Price-Fixing Inquiry Sends Pharmaceuticals Tumbling - The New York Times
Here's Why Teva Pharma Stock Is Soaring Today
Teva CEO Vigodman steps down as drugmaker seeks direction | The Times of Israel
20 States Accuse Generic Drug Companies of Price Fixing - The New York Times
